About Raremark
Raremark is a company based in London (United Kingdom) founded in 2007. Raremark has raised $8.75 million across 8 funding rounds from investors including Albion Capital, Ananda Impact Ventures and Oltre Impact. The company has 15 employees as of December 31, 2020. Raremark offers products and services including RareDisease.net Platform and Article and Forum Services. Raremark operates in a competitive market with competitors including AllStripes, Rare Disease, Althea Health, Power of Patients and My Lupus Team, among others.
- Headquarter London, United Kingdom
- Employees 15 as on 31 Dec, 2020
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epatient Network Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.75 M (USD)
in 8 rounds
-
Latest Funding Round
$2.68 M (USD), Seed
Dec 13, 2019
-
Investors
Albion Capital
& 5 more
-
Employee Count
15
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Raremark
Raremark offers a comprehensive portfolio of products and services, including RareDisease.net Platform and Article and Forum Services.
Digital space for rare disease information and patient forums.
Resources for managing rare diseases and emergencies.
Funding Insights of Raremark
Raremark has successfully raised a total of $8.75M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $2.68 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Raremark
Raremark has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Albion Capital, Ananda Impact Ventures and Oltre Impact.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed by Albion Capital.
|
Locked | Locked | Locked | |
|
Ananda Impact Ventures is focused on impact-driven investments.
|
Locked | Locked | Locked | |
|
Oltre Impact is recognized as Italy's first impact fund manager.
|
Locked | Locked | Locked |
Investor details for Raremark
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Raremark
Investment portfolio details for Raremark
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Raremark
Detailed financials for Raremark
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Raremark Comparisons
Peer comparison for Raremark
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Raremark
Raremark operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AllStripes, Rare Disease, Althea Health, Power of Patients and My Lupus Team, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of information to patients and communities with the medical data for rare diseases
|
|
| Locked | Locked | Locked |
Rare disease information and community support are provided online.
|
|
| Locked | Locked | Locked |
Facilitates patient suffering from rare diseases to create and maintain an online community
|
|
| Locked | Locked | Locked |
Brain injury symptoms are tracked through an online community platform.
|
|
| Locked | Locked | Locked |
Online community for lupus patients to share experiences and find advice.
|
Detailed competitors of Raremark
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Raremark
Complete news archive for Raremark
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raremark
Raremark was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Raremark is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Raremark is a funded company, having raised a total of $8.75M across 8 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Raremark is 15.
Founded in 2007 in London, United Kingdom, Raremark operates in the healthcare sector focused on rare diseases. A free online platform is provided to make scientific and medical knowledge accessible and understandable for patients and carers. Patient and carer networks are supported through dedicated online communities, facilitating information sharing and connections within the rare disease space.
Raremark's top competitors include AllStripes, Rare Disease and Althea Health.
Raremark offers RareDisease.net Platform and Article and Forum Services.
Raremark has 6 investors. Key investors include Albion Capital, Ananda Impact Ventures, Oltre Impact, Bayes Entrepreneurship Fund, and Cass Business School.
The valuation of Raremark is $7.91M as of Dec 2019.